# Neurofilament Light Protein in Peripheral Blood Used as a Biomarker for Neurotoxicity After Isolated Limb Perfusion.

> **NCT04460053** · NA · COMPLETED · sponsor: **Vastra Gotaland Region** · enrollment: 18 (actual)

## Conditions studied

- Malignant Melanoma

## Interventions

- **PROCEDURE:** Neurofilament light protein measurement in Isolated limb perfused patients

## Key facts

- **NCT ID:** NCT04460053
- **Lead sponsor:** Vastra Gotaland Region
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-12
- **Primary completion:** 2020-09-18
- **Final completion:** 2020-10-25
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04460053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04460053, "Neurofilament Light Protein in Peripheral Blood Used as a Biomarker for Neurotoxicity After Isolated Limb Perfusion.". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04460053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*